Press Releases (Page 136)
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) on behalf of Medpace stockholders. Our investigation concerns whether Medpace has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate... ❯❯❯
FIVE BELOW ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Five Below, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Five Below, Inc. (“Five Below” or the “Company”) (NASDAQ: FIVE) in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons and entities who purchased or otherwise acquired Five Below securities between March... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, American Airlines, and Bolt and Encourages Investors to Contact the Firm
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), American Airlines Group Inc. (NASDAQ: AAL), and Bolt Biotherapeutics (NASDAQ: BOLT). Stockholders have until the deadlines below to petition... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Marinus, 2U, Teradata, and Lamb Weston and Encourages Investors to Contact the Firm
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), 2U, Inc. (NASDAQ: TWOU), Teradata Corporation (NYSE: TDC), and Lamb Weston Holdings, Inc. (NYSE: LW). Stockholders have until the deadlines below to petition the court to serve as... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NIKE, FutureFuel, Roblox, and SeaStar and Encourages Investors to Contact the Firm
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of NIKE, Inc. (NYSE: NKE), FutureFuel Corp. (NYSE: FF), Roblox Corporation (NYSE: RBLX), and SeaStar Medical Holding Corporation (NASDAQ: ICU). Stockholders have until the deadlines below to petition the court to serve as lead... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor and MacroGenics and Encourages Investors to Contact the Firm
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Vicor Corporation (NASDAQ: VICR) and MacroGenics, Inc. (NASDAQ: MGNX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the... ❯❯❯
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Bioventus Inc. (NASDAQ: BVS) on behalf of long-term stockholders following a class action complaint that was filed against Bioventus on January 12, 2023 with a Class Period pursuant to the February 11, 2021 IPO. Our investigation concerns whether the board of directors... ❯❯❯
Global GDPR Services Business Report 2024: Pressing Need for Compliance Spurs Hyper-Growth - Forecast to 2030
Global GDPR Services Market Global GDPR Services Market Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "GDPR Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for GDPR Services is estimated at US$2.5 Billion in 2023 and is projected to reach US$7.7 Billion by 2030, growing at a CAGR of 17.2% from 2023 to 2030. This comprehensive report provides an... ❯❯❯
PARAGON 28 ALERT: Bragar Eagel & Squire, P.C. is Investigating Paragon 28, Inc. on Behalf of Paragon 28 Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA) on behalf of Paragon 28 stockholders. Our investigation concerns whether Paragon 28 has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate... ❯❯❯
CENTURI ALERT: Bragar Eagel & Squire, P.C. is Investigating Centuri Holdings, Inc. on Behalf of Centuri Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Centuri Holdings, Inc. (“Centuri” or the “Company”) (NYSE: CTRI) on behalf of Centuri stockholders. Our investigation concerns whether Centuri has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in... ❯❯❯